131 related articles for article (PubMed ID: 8550236)
1. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival.
Syrigos KN; Krausz T; Waxman J; Pandha H; Rowlinson-Busza G; Verne J; Epenetos AA; Pignatelli M
Int J Cancer; 1995 Dec; 64(6):367-70. PubMed ID: 8550236
[TBL] [Abstract][Full Text] [Related]
2. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies.
Bryan RT; Atherfold PA; Yeo Y; Jones LJ; Harrison RF; Wallace DM; Jankowski JA
J Pathol; 2008 Jun; 215(2):184-94. PubMed ID: 18393367
[TBL] [Abstract][Full Text] [Related]
3. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel.
Gagliardi G; Kandemir O; Liu D; Guida M; Benvestito S; Ruers TG; Benjamin IS; Northover JM; Stamp GW; Talbot IC
Virchows Arch; 1995; 426(2):149-54. PubMed ID: 7757285
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of p120 correlates with poor survival in patients with bladder cancer.
Syrigos KN; Karayiannakis A; Syrigou EI; Harrington K; Pignatelli M
Eur J Cancer; 1998 Dec; 34(13):2037-40. PubMed ID: 10070307
[TBL] [Abstract][Full Text] [Related]
6. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
7. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
Pignatelli M; Ansari TW; Gunter P; Liu D; Hirano S; Takeichi M; Klöppel G; Lemoine NR
J Pathol; 1994 Dec; 174(4):243-8. PubMed ID: 7884585
[TBL] [Abstract][Full Text] [Related]
8. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.
Ross JS; del Rosario AD; Figge HL; Sheehan C; Fisher HA; Bui HX
Hum Pathol; 1995 Sep; 26(9):940-4. PubMed ID: 7672793
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
Mahnken A; Kausch I; Feller AC; Krüger S
Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
[TBL] [Abstract][Full Text] [Related]
11. p130Cas, E-cadherin and β-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance.
Hu X; Ruan Y; Cheng F; Yu W; Zhang X; Larré S
Int J Urol; 2011 Sep; 18(9):630-7. PubMed ID: 21672035
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
Sun W; Herrera GA
Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
[TBL] [Abstract][Full Text] [Related]
14. The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder.
Fujisawa M; Miyazaki J; Takechi Y; Arakawa S; Kamidono S
World J Urol; 1996; 14 Suppl 1():S12-5. PubMed ID: 8738404
[TBL] [Abstract][Full Text] [Related]
15. The prognostic importance of e-cadherin and p53 gene expression in transitional bladder carcinoma patients.
Serdar A; Turhan C; Soner G; Cem SN; Bayram K; Damla BE; Erbil E
Int Urol Nephrol; 2005; 37(3):485-92. PubMed ID: 16307325
[TBL] [Abstract][Full Text] [Related]
16. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.
Bringuier PP; Umbas R; Schaafsma HE; Karthaus HF; Debruyne FM; Schalken JA
Cancer Res; 1993 Jul; 53(14):3241-5. PubMed ID: 8324734
[TBL] [Abstract][Full Text] [Related]
17. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
[TBL] [Abstract][Full Text] [Related]
18. Expression of classic cadherins type I in urothelial neoplastic progression.
Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
[TBL] [Abstract][Full Text] [Related]
19. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.
Keck B; Wach S; Kunath F; Bertz S; Taubert H; Lehmann J; Stöckle M; Wullich B; Hartmann A
Ann Surg Oncol; 2013 Jul; 20(7):2440-5. PubMed ID: 23108554
[TBL] [Abstract][Full Text] [Related]
20. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]